Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
55.9M
-
Shares change
-
+1.8M
-
Total reported value, excl. options
-
$19.5B
-
Value change
-
+$655M
-
Put/Call ratio
-
4.06
-
Number of buys
-
125
-
Number of sells
-
-111
-
Price
-
$348.08
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q1 2021
281 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q1 2021.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.9M shares
of 1.39B outstanding shares and own 4.04% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.7M shares), Capital International Investors (5.8M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (5.47M shares), BAILLIE GIFFORD & CO (4.43M shares), FMR LLC (4.42M shares), PRIMECAP MANAGEMENT CO/CA/ (3.89M shares), Temasek Holdings (Private) Ltd (2.75M shares), BlackRock Inc. (2.61M shares), Invesco Ltd. (2.49M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.19M shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.